Clinical Trial Update: Treatment of West Nile Virus With MGAWN1 [Phase 2]

View source ↗

Summary

Phase 2 trial of MGAWN1 for West Nile virus infection/West Nile neuroinvasive disease was terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis
• Flaccid Paralysis
• Meningitis
• West Nile Fever
• West Nile Neuroinvasive Disease
• West Nile Virus Infection

Drugs mentioned

• MGAWN1

Snippet

Sponsor: MacroGenics | Conditions: West Nile Neuroinvasive Disease, West Nile Virus Infection | Phase 2 | Status: TERMINATED | Results posted: 2012-11-07